TrueWealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Sell
1,086
-10
-0.9% -$10.2K 0.29% 62
2026
Q1
$1.01M Sell
1,096
-36
-3% -$36.5K 0.25% 75
2025
Q4
$1.22M Sell
1,132
-13
-1% -$12.4K 0.31% 60
2025
Q3
$873K Sell
1,145
-22
-2% -$16.4K 0.24% 82
2025
Q2
$910K Sell
1,167
-635
-35% -$493K 0.27% 67
2025
Q1
$1.49M Buy
1,802
+35
+2% +$29.1K 0.49% 46
2024
Q4
$1.36M Buy
1,767
+665
+60% +$551K 0.46% 48
2024
Q3
$976K Buy
1,102
+1
+0.1% +$899 0.33% 66
2024
Q2
$997K Sell
1,101
-84
-7% -$67.2K 0.37% 56
2024
Q1
$922K Buy
1,185
+122
+11% +$86.8K 0.36% 59
2023
Q4
$620K Sell
1,063
-26
-2% -$15.2K 0.24% 70
2023
Q3
$585K Buy
1,089
+26
+2% +$13.4K 0.25% 74
2023
Q2
$499K Hold
1,063
0.2% 83
2023
Q1
$365K Hold
1,063
0.15% 105
2022
Q4
$389K Hold
1,063
0.17% 100
2022
Q3
$344K Sell
1,063
-153
-13% -$48.5K 0.16% 99
2022
Q2
$394K Buy
1,216
+28
+2% +$8.4K 0.18% 99
2022
Q1
$328K Hold
1,188
0.15% 125
2021
Q4
$328K Buy
1,188
+127
+12% +$32.2K 0.15% 125
2021
Q3
$245K Hold
1,061
0.14% 120
2021
Q2
$244K Hold
1,061
0.14% 112
2021
Q1
$202K Buy
+1,061
New +$208K 0.13% 121

Other funds holding LLY

TrueWealth Advisors's LLY Position: Q2 2026 in Review

TrueWealth Advisors reduced its Eli Lilly (LLY) stake by 0.91% in Q2 2026, selling an estimated $10.2K and leaving 1,086 shares worth $1.3M. The position accounts for 0.29% of the portfolio, ranked #62.

TrueWealth Advisors first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.49M in Q1 2025. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TrueWealth Advisors held 1,086 shares of Eli Lilly worth $1.3M as of Q2 2026.
  • TrueWealth Advisors sold 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.29% of TrueWealth Advisors's portfolio in Q2 2026, its #62 holding.
  • TrueWealth Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • TrueWealth Advisors's Eli Lilly position peaked at $1.49M in Q1 2025.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TrueWealth Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.